Latest Posts
News, insights, and updates from RootPath.
-
Sequence to function in 3+ days, with data you can trust
The design-build-test-learn (DBTL) iterations in protein design demand rapid generation of high-quality yet affordable wet-lab data. Conventional CROs tend to lack agility, while many new, automation/AI-first cloud labs lack the experience or rigor in biologics drug development. RootPath’s BinderVerse offers you the best of both worlds.
Read more → -
Are your $k_{\text{off}}$ and $K_{\text{D}}$ measurements fooled by valency?
How to avoid rookie mistakes when selecting BLI/SPR format
Read more → -
Balancing speed and data quality in rapid antibody affinity testing
Mammalian cell-based expression systems using CHO or 293T cells have been the gold standard for expression of antibodies and antibody fragments for decades, for good reasons. We argue that they remain the top choices for rapid testing of binders in the age of AI-powered protein design. To empower your antibody design work, in the BinderVerse platform we can achieve a turnaround time (from AA sequence to binding curves, gene synthesis time included) as short as 6 days.
Read more → -
CAR-T R&D Superhighway: From sequences to T cell functions in 10 days
CAR-T structure is remarkably modular, yet CAR-T research requires experiences in many blended areas. We leverage our deep experience in T cell biology to digitize CAR-T R&D for protein designers.
Read more →
